Stimcell Energetics (STME) Net Cash Flow (2011 - 2026)
Stimcell Energetics' (STME) quarterly Net Cash Flow came in at -$36290.0 in Q1 2026, down 34.55% year-on-year from -$55448.5 in Q1 2025, and down 190.48% quarter-over-quarter from $40110.0 in Q4 2025.
Stimcell Energetics (STME) Net Cash Flow (2011 - 2026) Analysis & Trends
Stimcell Energetics' Net Cash Flow history runs 14 years deep, the most recent figure standing at -$36290.0 for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 34.55% year-over-year to -$36290.0 in Q1 2026; TTM through Feb 2026 was $3343.0, a 104.6% increase from a year earlier, with the FY2025 full-year figure at -$28742.0, up 47.61% from the prior year.
- Net Cash Flow slipped to -$36290.0 in Q1 2026 per STME's latest filing, from $40110.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $90753.0 in Q2 2023 and bottomed at -$40357.0 in Q3 2023.
- The 5-year median for Net Cash Flow is -$8142.0 (2025), against an average of -$1589.4.
- Across the five-year window, Net Cash Flow plunged 504.06% in 2022 and jumped 1500.08% in 2023, its largest moves.
- Year by year, Net Cash Flow stood at $8806.0 in 2022, then slumped by 501.18% to -$35328.0 in 2023, then soared by 138.16% to $13481.0 in 2024, then soared by 197.53% to $40110.0 in 2025, then plunged by 190.48% to -$36290.0 in 2026.
- Per Business Quant, the three latest STME Net Cash Flow figures stand at -$36290.0 (Q1 2026), $40110.0 (Q4 2025), and -$8142.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | -36,290.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -36,290.00 |
| Feb 28, 2026 | -36,290.00 |
| Nov 30, 2025 | 40,110.00 |
| Nov 30, 2025 | 40,110.00 |
| Aug 31, 2025 | -8,142.00 |
| Aug 31, 2025 | -8,142.00 |
| May 31, 2025 | 7,665.00 |
| May 31, 2025 | 7,665.00 |
| Feb 28, 2025 | -26,971.00 |
| Feb 28, 2025 | -26,971.00 |
| Nov 30, 2024 | 13,481.00 |
| Nov 30, 2024 | 13,481.00 |
| Aug 31, 2024 | -22,917.00 |
| Aug 31, 2024 | -22,917.00 |
| May 31, 2024 | -36,235.00 |
| May 31, 2024 | -36,235.00 |
| Feb 29, 2024 | 57,055.00 |
| Feb 29, 2024 | 57,055.00 |
| Nov 30, 2023 | -35,328.00 |
| Nov 30, 2023 | -35,328.00 |